Smead Capital Management’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-143,553
Closed -$2.69M 37
2020
Q4
$2.69M Buy
+143,553
New +$2.34M 0.16% 29
2014
Q1
Sell
-412,814
Closed -$17.9M 30
2013
Q4
$17.9M Sell
412,814
-49,708
-11% -$2.04M 2.47% 20
2013
Q3
$17.7M Sell
462,522
-69,269
-13% -$2.44M 2.86% 21
2013
Q2
$16.5M Buy
+531,791
New +$15.9M 3.34% 15

Other funds holding VTRS

Smead Capital Management's VTRS Position: Q1 2021 in Review

Smead Capital Management sold out of Viatris (VTRS) in Q1 2021, closing a stake of 143,553 shares — an estimated $2.69M sold.

Smead Capital Management first reported a position in VTRS in Q2 2013 and held it in 4 quarters. The position peaked at $17.9M in Q4 2013. 1,116 funds tracked by Wall St. Rank hold VTRS as of Q1 2021.

  • Smead Capital Management reported no remaining Viatris position as of Q1 2021 after selling out during the quarter.
  • Smead Capital Management sold 143,553 Viatris shares in Q1 2021, an estimated $2.69M.
  • Smead Capital Management first reported a position in Viatris in Q2 2013 and held it in 4 quarters.
  • Smead Capital Management's Viatris position peaked at $17.9M in Q4 2013.
  • 1,116 funds tracked by Wall St. Rank held Viatris as of Q1 2021.

Based on Smead Capital Management's 13F filing for Q1 2021, filed 4 May 2021.